Long-Term Effect of Dipeptidyl Peptidase-IV Inhibitors on Cardiovascular Events in Type 2 Diabetes Mellitus Middle-Age Patients: A Meta-Analysis

被引：0
|
作者：
Patel, Samir [1 ]
Patel, Palak [2 ]
Patel, Mihir [3 ]
机构：
[1] Western Reserve Hlth Educ, NEOMED, Youngstown, OH USA
[2] Qingdao Med Coll, Qingdao, Peoples R China
[3] St Marys Hosp, Waterbury, CT USA
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT-0971
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysis
    Dan Liu
    Biao Jin
    Wei Chen
    Peng Yun
    BMC Pharmacology and Toxicology, 20
  • [42] Impact of dipeptidyl peptidase-4 inhibitors on incidence of colorectal cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Fu, Rongrong
    Chen, Jingqi
    Fang, Yingying
    Wu, Qingping
    Zhang, Xiaoming
    Wang, Zhiyan
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2025, 16
  • [43] Risk of heart failure with dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
    Kundu, Amartya
    Sardar, Partha
    Ghosh, Sreeparna
    Patel, Parth
    Chatterjee, Saurav
    Meyer, Theo E.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 212 : 203 - 205
  • [44] A triumph for physiology driving drug discovery: the potential impact of dipeptidyl peptidase-IV inhibitors in type 2 diabetes
    Donnelly, Richard
    DIABETES OBESITY & METABOLISM, 2007, 9 (02): : 151 - 152
  • [45] Efficacy of dipeptidyl-peptidase-4 inhibitors and impact on β-cell function in Asian and Caucasian type 2 diabetes mellitus patients: A meta-analysis
    Cai, Xiaoling
    Han, Xueyao
    Luo, Yingying
    Ji, Linong
    JOURNAL OF DIABETES, 2015, 7 (03) : 347 - 359
  • [46] The efficacy and safety of dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus patients with severe renal impairment: a meta-analysis
    Chen, Maosheng
    Liu, Yueming
    Jin, Juan
    He, Qiang
    RENAL FAILURE, 2016, 38 (04) : 581 - 587
  • [47] Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis
    Karagiannis, Thomas
    Paschos, Paschalis
    Paletas, Konstantinos
    Matthews, David R.
    Tsapas, Apostolos
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [48] Comparative efficacy and safety of dipeptidyl peptidase-4 inhibitors in adults with type 2 diabetes mellitus: A network meta-analysis
    Wang, Gongquan
    Fu, Jia
    Li, Xiangjun
    Wang, Jiajia
    Zhai, Jiawei
    Du, Bing
    DIABETES OBESITY & METABOLISM, 2025, 27 (03): : 1217 - 1225
  • [49] Effect of Dipeptidyl Peptidase-4 Inhibitors on Bone Health in Patients with Type 2 Diabetes Mellitus
    Lee, Dong-Hwa
    Kim, Kyong Young
    Yoo, Min Young
    Moon, Hansol
    Ku, Eu Jeong
    Oh, Tae Keun
    Jeon, Hyun Jeong
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (20)
  • [50] Effect of dipeptidyl peptidase-4 inhibitors on fat metabolism in patients with type 2 diabetes mellitus
    Ametov, A. S.
    Gusenbekova, D. G.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (08) : 85 - 89
12345